Suraj Medical And Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 16-11-2024
- Paid Up Capital ₹ 5.83 M
as on 16-11-2024
- Company Age 35 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.88 Cr
as on 16-11-2024
- Revenue -17.45%
(FY 2023)
- Profit 4.55%
(FY 2023)
- Ebitda -37.61%
(FY 2023)
- Net Worth -41.87%
(FY 2023)
- Total Assets -5.61%
(FY 2023)
About Suraj Medical And Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.83 M.
The company currently has active open charges totaling ₹9.88 Cr.
Sudhir Luthra, Savita Luthra, Saurabh Luthra, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110UP1989PTC010975
- Company No.
010975
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jul 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Kanpur Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Suraj Medical And Diagnostics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhir Luthra  | Director | 24-Jul-1989 | Current |
| Savita Luthra | Director | 24-Jul-1989 | Current |
| Saurabh Luthra | Director | 08-Jun-2024 | Current |
| Richa Luthra | Director | 08-Jun-2024 | Current |
Financial Performance of Suraj Medical And Diagnostics.
Suraj Medical And Diagnostics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.45% decrease. The company also saw a slight improvement in profitability, with a 4.55% increase in profit. The company's net worth observed a substantial decline by a decrease of 41.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suraj Medical And Diagnostics?
In 2023, Suraj Medical And Diagnostics had a promoter holding of 80.53% and a public holding of 19.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
S S Corporate Print House Private LimitedActive 36 years 8 monthsSudhir Luthra and Savita Luthra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Creation Date: 23 Jan 2018 | ₹1.55 M | Open |
Uco Bank Creation Date: 25 May 2017 | ₹3.60 M | Open |
Uco Bank Creation Date: 26 Oct 2016 | ₹2.52 Cr | Open |
How Many Employees Work at Suraj Medical And Diagnostics?
Suraj Medical And Diagnostics has a workforce of 5 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suraj Medical And Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suraj Medical And Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
